highly significantp < 0.001
Combined use of oxytocin and ARM was 41.7% and 77.2% in misoprostol and Foley catheter group, respectively, and statistically it was very highly significant ( p < 0.001).
Combined use of oxytocin and ARM was 41.7% and 77.2% in misoprostol and Foley catheter group, respectively, and statistically it was very highly significant ( p < 0.001).